Empire Life Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-160,662
| Closed | -$2.61M | – | 97 |
|
|
2024
Q2 | $2.61M | Sell |
160,662
-9,173
| -5% | -$149K | 0.16% | 70 |
|
|
2024
Q1 | $3.14M | Sell |
169,835
-4,980
| -3% | -$92.1K | 0.19% | 64 |
|
|
2023
Q4 | $5.47M | Buy |
174,815
+467
| +0.3% | +$14.6K | 0.35% | 59 |
|
|
2023
Q3 | $3.63M | Sell |
174,348
-2,714
| -2% | -$56.6K | 0.27% | 60 |
|
|
2023
Q2 | $4.24M | Sell |
177,062
-461
| -0.3% | -$11K | 0.29% | 59 |
|
|
2023
Q1 | $3.34M | Buy |
177,523
+1,682
| +1% | +$31.7K | 0.24% | 62 |
|
|
2022
Q4 | $2.8M | Sell |
175,841
-2,011
| -1% | -$32K | 0.19% | 65 |
|
|
2022
Q3 | $2.91M | Buy |
177,852
+5,930
| +3% | +$97K | 0.22% | 64 |
|
|
2022
Q2 | $2.42M | Buy |
171,922
+3,301
| +2% | +$46.5K | 0.17% | 65 |
|
|
2022
Q1 | $4.08M | Buy |
168,621
+345
| +0.2% | +$8.36K | 0.26% | 64 |
|
|
2021
Q4 | $3.93M | Buy |
168,276
+323
| +0.2% | +$7.54K | 0.24% | 66 |
|
|
2021
Q3 | $2.79M | Buy |
167,953
+1,988
| +1% | +$33K | 0.18% | 69 |
|
|
2021
Q2 | $4.05M | Buy |
165,965
+5,147
| +3% | +$126K | 0.26% | 67 |
|
|
2021
Q1 | $4.15M | Buy |
160,818
+107,772
| +203% | +$2.78M | 0.29% | 68 |
|
|
2020
Q4 | $2.84M | Buy |
53,046
+22,520
| +74% | +$1.2M | 0.2% | 74 |
|
|
2020
Q3 | $1.26M | Buy |
+30,526
| New | +$1.26M | 0.1% | 79 |
|